What infections does sivextro treat?

What Infections does Sivextro Treat?

Sivextro is a medication used to treat bacterial infections caused by certain gram-positive bacteria, including those resistant to other antibiotics. According to its approval description by the FDA [1], Sivextro is indicated for the treatment of community-acquired bacterial pneumonia (CABP) in adults, including those with acute bacterial skin and skin structure infections (ABSSSI).

What Bacterial Strains is Sivextro Effective Against?

Sivextro is effective against bacterial strains of Gram-positive bacteria, such as Staphylococcus aureus (including methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA)), Streptococcus pneumoniae, and Enterococcus faecalis [1].

Why is Sivextro a Preferred Option?

Sivextro offers an alternative treatment option for infections caused by bacteria that are resistant to other antibiotics. According to DrugPatentWatch.com [2], Sivextro's active ingredient, tedizolid phosphate, is a bacteriostatic antibiotic, which means it inhibits bacterial growth and replication. This makes it an effective treatment option for infections that have developed resistance to other antibiotics.

Side Effects and Safety

Like all medications, Sivextro can cause side effects, including diarrhea, nausea, vomiting, and rash. Patients should consult their healthcare provider about potential side effects and any concerns they may have.

Pricing and Availability

The cost of Sivextro may vary depending on the patient's insurance coverage and location. Patients should consult their healthcare provider or pharmacist about pricing and availability.

Sources:

[1] FDA (2014). FDA Approves Sivextro (tedizolid phosphate) for Treatment of Certain Types of Skin and Skin Structure Infections.
[2] DrugPatentWatch.com. Tedizolid Phosphate (Sivextro).

https://www.druggaptentwatch.com/DrugPatentSearch/Tedizolid-Phosphate
https://www.druggaptentwatch.com/DrugPatentSearch/Sivextro